Seyed Ali Forouzannia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seyed Ali Forouzannia has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Arash Sarveazad
Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Fattaneh Khalaj
Digestive Diseases Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Hamed Ghorani
Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Science, Tehran, Iran
1 shared publication - Mahmoud Yousefifard
Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication Mohammadhossein Vazirizadeh-Mahabadi
Iran Univ Med Sci, Physiol Res Ctr, Tehran, Iran
1 shared publication- Mohammadhossein Vazirizadeh-Mahabadi
Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1) , 82
Application of radiomics in abdominal aortic aneurysm and endovascular aneurysm repair-related adverse events imaging: a systematic review
Background: Abdominal aortic aneurysm (AAA) carries high morbidity and mortality, while adverse events (AE) after endovascular aneurysm repair (EVAR) remain a major challenge. Accurate risk stratification is essential. Radiomics, by extracting quantitative imaging features, offers a noninvasive approach that may improve prediction of AAA outcomes and EVAR-related AE beyond conventional imaging. Main body: A search was conducted across Medline, Scopus, Embase, and Web of Science databases for articles published up to February 2024 to evaluate the application of radiomics in predicting the outcomes of AAA and diagnosing or predicting the AE related to EVAR. Inclusion criteria concentrated on observational studies that utilized a radiomics model based on the radiomic features extracted from imaging modalities to predict AAA outcomes and predict or diagnose EVAR-related AE. Eight studies involving 1729 observations met the inclusion criteria out of the 371 records yielded from the databases. Radiomics achieved a high area under the receiver operating characteristic (ROC) curve (AUROC) for predicting EVAR-related AE in three studies (up to 0.95), and it showed predictive value for AAA growth in three studies (AUROC 0.79–0.93) and rupture or repair in one study (AUROC 0.75). One study highlighted the diagnostic value of radiomics in post-EVAR endoleak detection using unenhanced computed tomography images (AUROC 0.91). Conclusion: Radiomics showed promising but preliminary results in predicting AAA outcomes and EVAR-related AE, providing a noninvasive tool for risk assessment. However, further research with larger cohorts and external validation of the radiomics models is essential to confirm its clinical applicability.
- 10 July 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1) , 82
Open AccessApplication of radiomics in abdominal aortic aneurysm and endovascular aneurysm repair-related adverse events imaging: a systematic review
Background: Abdominal aortic aneurysm (AAA) carries high morbidity and mortality, while adverse events (AE) after endovascular aneurysm repair (EVAR) remain a major challenge. Accurate risk stratification is essential. Radiomics, by extracting quantitative imaging features, offers a noninvasive approach that may improve prediction of AAA outcomes and EVAR-related AE beyond conventional imaging. Main body: A search was conducted across Medline, Scopus, Embase, and Web of Science databases for articles published up to February 2024 to evaluate the application of radiomics in predicting the outcomes of AAA and diagnosing or predicting the AE related to EVAR. Inclusion criteria concentrated on observational studies that utilized a radiomics model based on the radiomic features extracted from imaging modalities to predict AAA outcomes and predict or diagnose EVAR-related AE. Eight studies involving 1729 observations met the inclusion criteria out of the 371 records yielded from the databases. Radiomics achieved a high area under the receiver operating characteristic (ROC) curve (AUROC) for predicting EVAR-related AE in three studies (up to 0.95), and it showed predictive value for AAA growth in three studies (AUROC 0.79–0.93) and rupture or repair in one study (AUROC 0.75). One study highlighted the diagnostic value of radiomics in post-EVAR endoleak detection using unenhanced computed tomography images (AUROC 0.91). Conclusion: Radiomics showed promising but preliminary results in predicting AAA outcomes and EVAR-related AE, providing a noninvasive tool for risk assessment. However, further research with larger cohorts and external validation of the radiomics models is essential to confirm its clinical applicability.
- 1 February 2023
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 17 (2) , 102721
Can metformin use reduce the risk of stroke in diabetic patients? A systematic review and meta-analysis
- 1 February 2023
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 17 (2) , 102721
Can metformin use reduce the risk of stroke in diabetic patients? A systematic review and meta-analysis
- 1 January 2023
- Published by Maad Rayan Publishing Company
- Vol. 11 (1) , e25
Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta- Analysis
Introduction: In recent years, studies have provided evidence on the prognostic value of the leuko-glycemic index (LGI) in acute myocardial infarction (MI), but there is a lack of consensus. In addition, various reported cut-offs for LGI have raised concern regarding its clinical applicability. So, to conclude, through this systematic review and meta-analysis, we aimed to investigate all available evidence on the prognostic value of LGI in acute MI. Methods: Two independent researchers summarized records available in the four main databases of Medline (Via PubMed), Embase, Scopus, and Web of Science until 15 Sep 2022. Articles studying the prognostic value of the LGI in acute MI were included. Finally, sensitivity, specificity, prognostic odds ratio, and the area under the curve (AUC) for LGI were analyzed and reported. Results: Eleven articles were included (3701 patients, 72.1% male). Based on the analyses, AUC, sensitivity, and speci-ficity for LGI in prediction of mortality following acute MI were 0.77 (95% CI: 0.73 to 0.80), 0.75 (95% CI: 0.62 to 0.84), and 0.66 (95% CI: 0.51 to 0.78), respectively. Positive and negative post-test probability of LGI in prediction of mortality were 21% and 5%, respectively. AUC, sensitivity, and specificity for LGI in prediction of major cardiac complications after acute MI were 0.81 (95% CI: 0.77 to 0.84), 0.84 (95% CI: 0.70 to 0.92), and 0.64 (95% CI: 0.49 to 0.84), respectively. Also, the Positive and negative post-test probability of LGI in this regard were 59% and 13%, respectively. Conclusion: Although the results demonstrated that the LGI could predict mortality and acute cardiac complication after MI, the low post-test probability of LGI in risk stratification of patients raises questions regarding its applicability. Nevertheless, as most of the available studies have been conducted in the Latino/Hispanic population, further evidence is warranted to generalize the validity of this tool to other racial populations.
- 1 January 2023
- Published by Maad Rayan Publishing Company
- Vol. 11 (1) , e25
Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta- Analysis
Introduction: In recent years, studies have provided evidence on the prognostic value of the leuko-glycemic index (LGI) in acute myocardial infarction (MI), but there is a lack of consensus. In addition, various reported cut-offs for LGI have raised concern regarding its clinical applicability. So, to conclude, through this systematic review and meta-analysis, we aimed to investigate all available evidence on the prognostic value of LGI in acute MI. Methods: Two independent researchers summarized records available in the four main databases of Medline (Via PubMed), Embase, Scopus, and Web of Science until 15 Sep 2022. Articles studying the prognostic value of the LGI in acute MI were included. Finally, sensitivity, specificity, prognostic odds ratio, and the area under the curve (AUC) for LGI were analyzed and reported. Results: Eleven articles were included (3701 patients, 72.1% male). Based on the analyses, AUC, sensitivity, and speci-ficity for LGI in prediction of mortality following acute MI were 0.77 (95% CI: 0.73 to 0.80), 0.75 (95% CI: 0.62 to 0.84), and 0.66 (95% CI: 0.51 to 0.78), respectively. Positive and negative post-test probability of LGI in prediction of mortality were 21% and 5%, respectively. AUC, sensitivity, and specificity for LGI in prediction of major cardiac complications after acute MI were 0.81 (95% CI: 0.77 to 0.84), 0.84 (95% CI: 0.70 to 0.92), and 0.64 (95% CI: 0.49 to 0.84), respectively. Also, the Positive and negative post-test probability of LGI in this regard were 59% and 13%, respectively. Conclusion: Although the results demonstrated that the LGI could predict mortality and acute cardiac complication after MI, the low post-test probability of LGI in risk stratification of patients raises questions regarding its applicability. Nevertheless, as most of the available studies have been conducted in the Latino/Hispanic population, further evidence is warranted to generalize the validity of this tool to other racial populations.